What is the recommended pharmacologic treatment for persistent hiccups lasting more than 48 hours?

Pharmacologic Treatment for Persistent Hiccups

For persistent hiccups lasting more than 48 hours, baclofen is the recommended first-line pharmacologic agent, with chlorpromazine as an alternative if baclofen fails or is contraindicated.

Treatment Algorithm

First-Line Therapy: Baclofen

• Dosing: Start with 5-10 mg orally three times daily, titrate up to 20 mg three times daily as needed
• Evidence: Baclofen is supported by randomized controlled trials and has the best safety profile for long-term use 1, 2
• Mechanism: Acts on the central hiccup reflex arc through GABA-B receptor agonism
• Advantages: Lower risk of side effects compared to neuroleptics, particularly during prolonged therapy 2

Second-Line Therapy: Chlorpromazine

• Dosing: 12.5-25 mg orally or rectally every 6-12 hours; use lower doses (12.5 mg) in older patients 3
• Evidence: Only FDA-approved medication specifically for hiccups 1
• Success rate: 83% in COVID-19-related persistent hiccups 4
• Important caveats:
  • Monitor for QTc prolongation - obtain baseline ECG if using long-term 5
  • Risk of extrapyramidal symptoms, orthostatic hypotension, and sedation 3
  • Avoid in patients with Parkinson's disease or dementia with Lewy bodies

Alternative Agents (If First Two Fail)

Gabapentin

• Supported by randomized controlled trials 1, 2
• Similar safety profile to baclofen for long-term use
• Consider as co-first-line with baclofen

Metoclopramide

• Dosing: 5-10 mg orally four times daily, 30 minutes before meals and at bedtime 6
• Best for: Peripheral causes of hiccups, particularly gastroesophageal reflux or gastroparesis 7, 2
• Evidence: Randomized controlled trial support 1
• Limitation: 0% success rate in COVID-19 cases, suggesting limited efficacy for central causes 4

Special Populations

Palliative Care/Terminal Illness

• Midazolam: 2.5-5 mg subcutaneously every 2-4 hours as needed 8, 7
• Can be given as continuous subcutaneous infusion (10 mg over 24 hours) if needed frequently
• Particularly useful when patient cannot swallow

Renal Dysfunction

• Consider that uremia itself may be the cause 9
• Reduce midazolam dose to 5 mg over 24 hours if eGFR <30 mL/min 8
• Hemodialysis may resolve intractable hiccups in end-stage renal disease 9

Critical Clinical Pearls

Identify and treat underlying causes first:

• Gastroesophageal reflux: Trial of proton pump inhibitor (avoid omeprazole if using other medications metabolized by CYP1A2) 10, 11
• Gastric distension: Rule out gastroparesis, constipation, bowel obstruction 6
• Central nervous system lesions: Consider imaging if neurologic signs present
• Metabolic: Check for uremia, electrolyte abnormalities

COVID-19 consideration:

• In males presenting with persistent hiccups, even without respiratory symptoms, obtain SARS-CoV-2 testing and chest imaging 4
• All reported COVID-19 cases with persistent hiccups had lung involvement on imaging

Avoid common pitfalls:

• Do not use haloperidol as first-line despite its mention in guidelines - it's primarily for delirium, not hiccups 3
• Metoclopramide works best for peripheral/GI causes, not central causes 7, 2
• Chlorpromazine requires cardiac monitoring for QTc prolongation, especially with concurrent medications 5

When medications fail:

• Consider interventional procedures: vagal or phrenic nerve block/stimulation 7
• Reassess for missed underlying pathology
• In palliative patients, continuous subcutaneous midazolam infusion may provide relief 7